{"id":7415,"date":"2026-05-20T15:03:43","date_gmt":"2026-05-20T19:03:43","guid":{"rendered":"https:\/\/www.mantrapharma.ca\/?post_type=webinars&#038;p=7415"},"modified":"2026-09-22T19:58:26","modified_gmt":"2026-09-22T23:58:26","slug":"online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management","status":"publish","type":"webinars","link":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/","title":{"rendered":"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC)"},"featured_media":3869,"template":"","meta":{"_acf_changed":false},"class_list":["post-7415","webinars","type-webinars","status-publish","has-post-thumbnail","hentry"],"acf":{"general_infos":{"date":null,"hour":null,"unpublish_date":"","public":[{"public_cible":"Healthcare professionals"}],"accreditation":"0.75 CEU (OPQ)","time":"45 minutes","formateur":[7390]},"intro":"","webinar_content":[{"acf_fc_layout":"title_and_text","title":"Votre formation en 3 \u00e9tapes","text":"<p><strong>Please note: This online training program is available in French only.<\/strong><\/p>\n<p>1. \u00c9coutez la capsule <a style=\"font-weight: 500;\" href=\"#video\">vid\u00e9o<\/a><br \/>\n2. Compl\u00e9tez l\u2019<a style=\"font-weight: 500;\" href=\"#evaluation\">\u00e9valuation<\/a><br \/>\n3. Recevez votre attestation de formation continue<\/p>\n<p><strong>Dr Samer Mansour<\/strong><br \/>\nCardiologue h\u00e9modynamicien CHUM et professeur adjoint de clinique D\u00e9partement de m\u00e9decine, Universit\u00e9 de Montr\u00e9al<\/p>\n"},{"acf_fc_layout":"beige_bloc","title":"Objectifs d'apprentissage","text":"<p>\u00c0 la fin de ce programme de formation, les participants seront en mesure de :<\/p>\n<ol>\n<li>Actualiser les connaissances des nouvelles lignes directrices canadiennes en dyslipid\u00e9mie;<\/li>\n<li>Distinguer et assimiler les changements par rapport aux recommandations pr\u00e9c\u00e9dentes;<\/li>\n<li>D\u00e9terminer quels patients \u00e0 risque \u00e9lev\u00e9 pourraient b\u00e9n\u00e9ficier d\u2019une baisse additionnelle de leur taux de C-LDL;<\/li>\n<li>Int\u00e9grer les options th\u00e9rapeutiques dans la pratique.<\/li>\n<\/ol>\n<p><em>Cette activit\u00e9 de formation continue est accr\u00e9dit\u00e9e par l\u2019Ordre des pharmaciens du Qu\u00e9bec. Le num\u00e9ro d\u2019accr\u00e9ditation est 260186 et le nombre d\u2019heures admissibles est de 0,75 heure(s).<\/em><\/p>\n"},{"acf_fc_layout":"title_and_text","title":"Suivre la formation - 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie","text":"<p><strong>Dur\u00e9e :<\/strong> 45 minutes | <strong>Accr\u00e9ditation :<\/strong> 0,75 UFC<br \/>\n<strong id=\"evaluation\">\u00c9valuation : <\/strong><a style=\"color: #e87722; text-decoration: underline; font-weight: 500;\" href=\"https:\/\/fr.surveymonkey.ca\/r\/evaluation-10-notions-dyslipidemie\" target=\"_blank\" rel=\"noopener\">Compl\u00e9ter l\u2019\u00e9valuation<\/a><\/p>\n<div id=\"video\" style=\"max-width: 800px; width: 100%; margin: 20px 0;\">\n<div style=\"position: relative; padding-top: 56.25%;\"><iframe style=\"position: absolute; inset: 0; width: 100%; height: 100%; border: 0;\" title=\"10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslip\u00e9mie\" src=\"https:\/\/player.vimeo.com\/video\/1181209635?h=37ec6e3433&amp;badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" allowfullscreen=\"allowfullscreen\"><br \/>\n<\/iframe><\/div>\n<\/div>\n"}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Mantra Pharma\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/mantrapharma\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-22T23:58:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/09\/Image_dislepidemie-3-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/\",\"url\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/\",\"name\":\"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.mantrapharma.ca\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Image_dislepidemie-3-scaled.jpeg\",\"datePublished\":\"2026-05-20T19:03:43+00:00\",\"dateModified\":\"2026-09-22T23:58:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.mantrapharma.ca\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Image_dislepidemie-3-scaled.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.mantrapharma.ca\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Image_dislepidemie-3-scaled.jpeg\",\"width\":2560,\"height\":1435,\"caption\":\"Anatomy illustration showcasing the obstruction of a vein or artery caused by plaque. Gain insights into the impact of plaque buildup on blood flow and cardiovascular health. Realistic illustration created by Generative AI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/webinars\\\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.mantrapharma.ca\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.mantrapharma.ca\\\/\",\"name\":\"Mantra Pharma\",\"description\":\"Pour aider \u00e0 mieux soigner les gens.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.mantrapharma.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#organization\",\"name\":\"Mantra Pharma\",\"url\":\"https:\\\/\\\/www.mantrapharma.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.mantrapharma.ca\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Calque_3.svg\",\"contentUrl\":\"https:\\\/\\\/www.mantrapharma.ca\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/Calque_3.svg\",\"width\":1,\"height\":1,\"caption\":\"Mantra Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.mantrapharma.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/mantrapharma\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/mantrapharma\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/","og_locale":"en_US","og_type":"article","og_title":"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma","og_url":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/","og_site_name":"Mantra Pharma","article_publisher":"https:\/\/www.facebook.com\/mantrapharma\/","article_modified_time":"2026-09-22T23:58:26+00:00","og_image":[{"width":2560,"height":1435,"url":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/09\/Image_dislepidemie-3-scaled.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/","url":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/","name":"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC) | Mantra Pharma","isPartOf":{"@id":"https:\/\/www.mantrapharma.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/#primaryimage"},"image":{"@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/09\/Image_dislepidemie-3-scaled.jpeg","datePublished":"2026-05-20T19:03:43+00:00","dateModified":"2026-09-22T23:58:26+00:00","breadcrumb":{"@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/#primaryimage","url":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/09\/Image_dislepidemie-3-scaled.jpeg","contentUrl":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/09\/Image_dislepidemie-3-scaled.jpeg","width":2560,"height":1435,"caption":"Anatomy illustration showcasing the obstruction of a vein or artery caused by plaque. Gain insights into the impact of plaque buildup on blood flow and cardiovascular health. Realistic illustration created by Generative AI"},{"@type":"BreadcrumbList","@id":"https:\/\/www.mantrapharma.ca\/en\/webinars\/online-10-key-concepts-ccs-guidelines-on-dyslipidemia-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.mantrapharma.ca\/en\/"},{"@type":"ListItem","position":2,"name":"ONLINE (French). 10 notions importantes dans les recommandations de la SCC sur la prise en charge de la dyslipid\u00e9mie (0,75 UFC)"}]},{"@type":"WebSite","@id":"https:\/\/www.mantrapharma.ca\/#website","url":"https:\/\/www.mantrapharma.ca\/","name":"Mantra Pharma","description":"Pour aider \u00e0 mieux soigner les gens.","publisher":{"@id":"https:\/\/www.mantrapharma.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mantrapharma.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.mantrapharma.ca\/#organization","name":"Mantra Pharma","url":"https:\/\/www.mantrapharma.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mantrapharma.ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/02\/Calque_3.svg","contentUrl":"https:\/\/www.mantrapharma.ca\/wp-content\/uploads\/2024\/02\/Calque_3.svg","width":1,"height":1,"caption":"Mantra Pharma"},"image":{"@id":"https:\/\/www.mantrapharma.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/mantrapharma\/","https:\/\/www.linkedin.com\/company\/mantrapharma\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/webinars\/7415","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/webinars"}],"about":[{"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/types\/webinars"}],"version-history":[{"count":4,"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/webinars\/7415\/revisions"}],"predecessor-version":[{"id":7441,"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/webinars\/7415\/revisions\/7441"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/media\/3869"}],"wp:attachment":[{"href":"https:\/\/www.mantrapharma.ca\/en\/wp-json\/wp\/v2\/media?parent=7415"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}